These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9340439)

  • 1. [Combined diagnosis of primary lung cancer using immunological tests].
    Bakhlaev IE; Oleínik EK; Ageenko AI; Erkhov VS; Trakhtenberg AK
    Klin Med (Mosk); 1997; 75(8):45-8. PubMed ID: 9340439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Informative value of diagnostic tables for detection of tuberculosis and related lung diseases].
    Knoring BE; Savurenkova EP
    Probl Tuberk; 1990; (12):57-60. PubMed ID: 2084698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of monoclonal antibodies for immunodiagnosis of lung cancer].
    Romanova RI; Gergert VI; Filippov VP; Goncharskaia MA; Evgushchenko GV; Sidorova NF; Gorelova LA
    Probl Tuberk; 1997; (5):44-8. PubMed ID: 9454255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunodiagnosis of lung cancer with monoclonal antibodies.
    Egri G; Takáts A
    Med Sci Monit; 2005 Sep; 11(9):RA296-300. PubMed ID: 16127376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy.
    Okasaka T; Usami N; Mitsudomi T; Yatabe Y; Matsuo K; Yokoi K
    J Surg Oncol; 2008 Dec; 98(7):510-4. PubMed ID: 18802955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis].
    Zhang X; Li TR; Chen ZS; Ouyang XN
    Ai Zheng; 2006 Jan; 25(1):66-8. PubMed ID: 16405752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients.
    Aoe K; Hiraki A; Yamazaki K; Nakamura Y; Murakami T; Maeda T; Nishimura M; Sugi K; Ueoka H
    Int J Oncol; 2006 Jul; 29(1):65-72. PubMed ID: 16773186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current bronchological methods of diagnosis of lung cancer].
    Gerasin VA; Kartavova VA; Palamarchuk GF
    Vestn Khir Im I I Grek; 1983 Jun; 130(6):23-6. PubMed ID: 6612933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of different combinations of immunological signs for differential diagnosis of lung diseases].
    Knoring BE; Saburenkova EP; Feigin MI
    Probl Tuberk; 1991; (7):53-6. PubMed ID: 1754592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
    Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
    Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities of computerized immunodiagnosis of tuberculosis and related lung diseases].
    Knoring BE; Savurenkova EP; Sergeev ST; Ushakov AIu
    Probl Tuberk; 1991; (8):9-12. PubMed ID: 1758868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer.
    Egloff AM; Weissfeld J; Land SR; Finn OJ
    Ann N Y Acad Sci; 2005 Dec; 1062():29-40. PubMed ID: 16461786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
    Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive scintigraphy in the diagnosis of lung cancer].
    Fadeev NP; Barchuk AS; Keller IuM; Mitreĭkin VF; Tret'iakova OI
    Vopr Onkol; 1977; 23(5):19-30. PubMed ID: 888414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic thoracotomy as the final stage of morphological verification of peripheral lung cancer].
    Trakhtenberg AKh; Zakharchenkov AV; Anikin VA
    Khirurgiia (Mosk); 1984 Jun; (6):21-6. PubMed ID: 6748519
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interleukin 3 (IL-3) in diagnosis and monitoring of non-small-cell lung cancer].
    Mroczko B; Szmitkowski M; Czygier M
    Przegl Lek; 1999; 56(12):763-6. PubMed ID: 10789186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.
    Ikeda S; Fujimori M; Shibata S; Okajima M; Ishizaki Y; Kurihara T; Miyata Y; Iseki M; Shimizu Y; Tokumoto N; Ozaki S; Asahara T
    BMC Cancer; 2006 Feb; 6():31. PubMed ID: 16451736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.